Resposta Rápida — O que é o Selank?
Selank is a 7-amino-acid synthetic heptapeptide developed at the Russian Academy of Sciences as an analog of the endogenous immunomodulatory peptide tuftsin. In published studies it acts as an anxiolytic nootropic, modulating GABAergic, serotonergic, and enkephalin signalling and upregulating BDNF expression without the sedation or dependence profile of benzodiazepines. Supplied in 5 mg and 10 mg lyophilized vials.
📦 Cada encomenda está coberta pela nossa Política de Garantia de Reenvio — se a sua encomenda não chegar no prazo de 20 dias úteis, reenviamo-la.
| Especificação | Detalhe |
|---|---|
| Número CAS | 129954-34-3 |
| Fórmula Molecular | C33H57N11O9 |
| Peso Molecular | 751.88 Da |
| Sequência | Thr-Lis-Pro-Arg-Pro-Gli-Pro-NH2 (TKPRPGP-NH2, 7 aminoácidos; análogo amidado na extremidade C-terminal da tuftsina) |
| Forma | Pó liofilizado (branco a branco sujo) |
| Pureza | ≥99% (HPLC verificado, COA disponível mediante pedido) |
| Armazenamento | Liofilizado: 2–8 °C (frigorífico) para stock de trabalho; −20 °C para armazenamento a longo prazo de frascos não abertos. Reconstituído: 2–8 °C, utilizar no prazo de ~30 dias. Proteger da luz. Não congelar-descongelar a solução reconstituída. |
| Solubilidade | Bacteriostatic water (recommended) or sterile water for shorter use windows. Compatible with intranasal vehicle formulations. |
O Que É o Selank?
Selank is a synthetic heptapeptide developed in the 1990s at the Institute of Molecular Genetics of the Russian Academy of Sciences, the same clinical that developed Semax. It is structurally an analog of the endogenous immunomodulatory tetrapeptide tuftsin (TKPR), extended at the C-terminus with a Pro-Gly-Pro tail that confers proteolytic stability and an amidated C-terminus. The tail extension dramatically extends plasma half-life relative to native tuftsin, which is degraded within minutes, while preserving the immunomodulatory activity of the parent peptide. Selank’s well-characterised sequence is TKPRPGP-NH2, peso molecular 751,88 Da, fórmula empírica C33H57N11O9. It is supplied as a high-purity lyophilized powder for reconstitution with bacteriostatic water. In Russia, Selank is approved as a prescription anxiolytic under the name Selank (intranasal spray); outside the post-Soviet bloc it is not approved by the FDA, EMA, MHRA, or any other major regulator. For sister-peptide studies, see our Semax página de produto.
Mecanismo de Ação — Vias GABAérgicas, Serotoninérgicas e de BDNF
What makes Selank distinctive among anxiolytic compounds is its perfil de neuromodulação multi-vias sem ligação direta ao recetor GABAA benzodiazepine site — each contributing to the observed anxiolytic and nootropic phenotype in published studies:
- Modulação GABAérgica sem ligação ao local das benzodiazepinas — Selank potentiates GABA-mediated inhibition through allosteric effects distinct from the benzodiazepine binding pocket. In rodent study models it raises seizure threshold and produces anxiolysis on elevated-plus-maze and open-field tests, but without the sedation, motor coordination loss, dependence liability, or rebound anxiety seen with diazepam. This distinct mode of GABA modulation is the most-studied aspect of Selank’s pharmacology.
- Sinalização serotoninérgica e encefalinérgica — Published studies has documented increased serotonin metabolism (5-HIAA / 5-HT ratio) in cortical and limbic regions following Selank administration in rodents, alongside upregulation of enkephalin gene expression. The combined serotonergic and enkephalinergic signal is thought to contribute to mood-modulatory and stress-resilience effects in chronic-stress study models.
- Expressão de BDNF e neuroplasticidade — Selank raises brain-derived neurotrophic factor (BDNF) expression in the hippocampus and prefrontal cortex in published studies, a mechanism increasingly recognised as central to the long-term effects of mood-modulatory compounds. BDNF upregulation also underpins Selank’s nootropic profile — improved memory consolidation and learning performance in rodent maze tasks.
Selank is intranasally bioavailable (one of the very few peptides with documented mucosal absorption), which is the primary administration route in published Russian and Eastern European studies. The intranasal route bypasses first-pass metabolism and delivers peptide directly across the cribriform plate into central compartments, producing CNS effects within minutes of administration. Subcutaneous administration is also documented in preclinical studies and produces a similar pharmacological profile with slightly slower onset.
Published Evidence
Selank is used in clinical contexts that investigate:
- Farmacologia ansiolítica — testes de labirinto em cruz elevado, campo aberto e interação social em modelos de roedores com ansiedade generalizada; braços comparativos contra benzodiazepinas (diazepam) e SSRIs (Kozlovskaya et al., Eksp Klin Farmakol; Inozemtsev et al., Bull Exp Biol Med)
- Stress resilience and HPA-axis studies — modelos de stress crónico leve, stress por contenção e desamparo aprendido; dinâmica do cortisol e ACTH
- BDNF and neuroplasticity studies — expressão de BDNF no hipocampo e córtex pré-frontal, morfologia das espinhas dendríticas, eletrofisiologia da potenciação a longo prazo
- Cognitive and memory studies — Labirinto aquático de Morris, reconhecimento de objeto novo, esquiva passiva; efeitos nootrópicos independentes de ansiolise
- Imunomodulação — Selank inherits tuftsin’s immunomodulatory activity, with documented effects on cytokine balance (TNF-α, IL-6, IFN-γ) and macrophage function in published studies
- Comparative studies vs benzodiazepines — Comparação direta com diazepam, alprazolam e fenazepam quanto à eficácia ansiolítica, potencial de dependência e recaída; o perfil de abstinência limpo do Selank é um dos resultados mais citados na literatura russa
- Sister-peptide studies — comparação com Semax (a sister heptapeptide from the same clinical) for nootropic and neuroprotective effects.
For broader context on small-peptide neuromodulation and nootropic studies, see Semax como o comparador nootrópico canónico desenvolvido na Rússia, Epitalon for pineal-peptide longevity studies, and BPC-157 for the parallel small-peptide healing-compound. Browse the full catálogo de péptidos para encontrar compostos relacionados.
Forças e Concentrações Disponíveis
MedsBase stocks Selank in two lyophilized vial sizes calibrated to typical protocol lengths. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats with full reconstitution guidance:
| Força do frasco | Caso de uso típico | Tamanhos das embalagens |
|---|---|---|
| 5 mg | Short protocols, pilot dosing, intranasal-vehicle formulation studies | 10, 20 ou 30 frascos |
| 10 mg | Standard strength, extended protocols, lowest per-mg cost | 10, 20 ou 30 frascos |
Both strengths are the same chemical form (lyophilized powder, 99%+ HPLC purity). Higher-mg vials require smaller reconstitution volumes per unit dose, which is useful when users want to minimise injection or intranasal-delivery volume in rodent protocols.
Comparação — Selank vs Semax
Selank e Semax are sister peptides developed at the same Russian clinical (Institute of Molecular Genetics, Russian Academy of Sciences) and are often compared in studies because they share heptapeptide architecture, intranasal bioavailability, and Russian regulatory history but differ substantially in primary pharmacological action. Selank is the canonical anxiolytic of the pair; Semax is the canonical nootropic/neuroprotective.
| Critério | Selank | Semax |
|---|---|---|
| Comprimento | 7 aminoácidos (heptapeptídeo) | 7 aminoácidos (heptapeptídeo) |
| Péptido parental | Tuftsina (TKPR) | Fragmento de ACTH(4-10) |
| Mecanismo primário | Modulação de GABA, BDNF, encefalina | BDNF, recetores de melanocortina, dopamina |
| Primary signal | Ansiolítico, resiliência ao stress | Nootrópico, neuroprotetor, foco |
| Typical dose (intranasal) | 300–900 mcg/dia | 200–1.000 mcg/dia |
| Uso clínico russo | Ansiolítico aprovado (intranasal) | Nootrópico aprovado / recuperação de AVC (intranasal) |
| Stacking in studies | Frequentemente combinado com Semax para efeito ansiolítico+nootrópico complementar | Frequentemente combinado com Selank |
Because the two peptides act on complementary axes — Selank on GABA/anxiolytic, Semax on melanocortin/dopaminergic/nootropic — they are frequently co-administered in protocols investigating cognitive performance under stress, where both arms (calm and focus) contribute to the studied phenotype.
Armazenamento e Reconstituição
Antes da reconstituição: armazenar frascos liofilizados refrigerados a 2–8 °C na embalagem original para stock de trabalho a curto prazo. Para armazenamento a longo prazo sem abertura, congelar a −20 °C. O Selank liofilizado é estável sob refrigeração até 24 meses e a −20 °C até 36 meses. Evitar ciclos de congelação-descongelação no pó liofilizado. Procedimento de reconstituição: inject bacteriostatic water down the side wall of the peptide vial (not directly onto the lyophilized cake). For a 5 mg vial, 1.0 mL of bacteriostatic water yields a 5 mg/mL working concentration; 0.1 mL delivers a 500 mcg dose. Swirl gently — do não shake — and allow 2–5 minutes for full dissolution. A correctly reconstituted solution should be clear and colourless. For intranasal-vehicle formulations, the reconstituted solution can be transferred to a calibrated nasal-spray bottle delivering ~100 μL per pump. Após reconstituição: armazene refrigerado a 2–8 °C e utilize dentro de 30 dias para estabilidade ótima. Não congele a solução reconstituída — ciclos de congelação-descongelação degradam a integridade do péptido. Descarte qualquer frasco que apresente turvação, precipitado ou descoloração.
Perguntas Frequentes
What is Selank used for in studies?
Selank is used in studies investigating anxiolytic pharmacology, stress resilience, BDNF and neuroplasticity, cognitive performance, immunomodulation, and head-to-head comparison against benzodiazepines. It is the most-cited Russian-developed anxiolytic peptide in the literature. The pharmaceutical-grade Selank sold here is não FDA-approved and is supplied strictly for clinical studies use only.
Em que é que o Selank difere do Semax?
Both are 7-amino-acid heptapeptides from the same Russian clinical and share intranasal bioavailability, but their mechanisms differ. Selank is derived from the immunomodulatory peptide tuftsin and acts predominantly via GABAergic, enkephalinergic, and BDNF pathways — canonical arm: anxiolysis. Semax is derived from ACTH(4-10) and acts via melanocortin receptors, BDNF, and dopaminergic modulation — canonical arm: nootropic and neuroprotection. The two are frequently co-administered in studies because the effects are complementary rather than overlapping.
What is the typical Selank dose?
Published Russian protocols typically use 300–900 mcg per day administered intranasally in 3 divided doses, or equivalent subcutaneous doses. A 5 mg vial reconstituted with 1.0 mL bacteriostatic water yields 5 mg/mL — 0.1 mL equals 500 mcg, a typical single-dose studies aliquot.
O Selank é aprovado pela FDA?
No. Selank is not approved by the FDA, EMA, MHRA, or any major Western regulator. It is approved in Russia as a prescription anxiolytic under the brand name Selank (intranasal spray, ZAO Pharm-Sintez).
Como deve ser armazenado o Selank?
Frascos liofilizados: refrigerados a 2–8 °C para stock de trabalho a curto prazo, ou −20 °C para armazenamento a longo prazo de frascos não abertos. Solução reconstituída: refrigerada a 2–8 °C, utilizar no prazo de 30 dias. Não congelar a solução reconstituída — os ciclos de congelação-descongelação degradam o péptido. Proteger da luz direta em todos os momentos.
Como devo reconstituir o Selank?
Siga o procedimento de reconstituição acima. Adicione água bacteriostática pela parede lateral do frasco (não diretamente sobre o pó liofilizado), agite suavemente e aguarde 2 a 5 minutos para dissolução completa. Não não Agite o frasco. Uma solução corretamente reconstituída é transparente e incolor. Para um frasco de 5 mg + 1,0 mL de diluente, a concentração de trabalho é de 5 mg/mL.
Que dosagens estão disponíveis na MedsBase?
MedsBase carries Selank in 5 mg and 10 mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis available on request.
Can Selank be administered intranasally in studies?
Yes — intranasal administration is the primary administration route in Russian and Eastern European published studies. Selank is one of the few peptides with documented intranasal bioavailability, attributable to its small size (7 aa, ~752 Da) and amidated C-terminus. The route bypasses first-pass metabolism and delivers peptide across the cribriform plate into central compartments within minutes of administration. Subcutaneous and intramuscular routes also work in preclinical models.
Can Selank and Semax be stacked in studies?
Yes. Selank and Semax are frequently co-administered in published studies because their mechanisms are complementary. Selank provides anxiolytic and stress-buffering effects via GABA/enkephalin/BDNF pathways; Semax provides nootropic and neuroprotective effects via melanocortin/dopaminergic/BDNF pathways. The combination is particularly studied in study models of cognitive performance under stress.
Does Selank cause side reported effects?
Published preclinical and Russian clinical studies has reported a notably clean safety profile at typical doses, with no consistent sedation, motor-coordination effects, dependence liability, or rebound on discontinuation — in clear contrast to benzodiazepine comparator arms. Long-term safety data outside Russia is limited because the peptide has not undergone Western regulatory review.
Qual é a meia-vida do Selank?
In preclinical studies, Selank has an estimated plasma half-life of approximately 15–30 minutes following intranasal administration, far longer than the parent peptide tuftsin (under 5 minutes). The short plasma half-life is offset by central-compartment accumulation following intranasal delivery and downstream effects on BDNF and gene expression that persist beyond plasma clearance.
How long does Selank take to show effects in preclinical studies?
Acute anxiolytic effects on elevated-plus-maze and open-field tests are detectable within 30–60 minutes of intranasal administration. BDNF and gene-expression effects accumulate over 7–14 days of regular dosing and underpin the longer-term mood-modulatory and nootropic phenotype observed in chronic-stress study models.
Posso encomendar Selank para envio internacional?
Sim. A MedsBase envia Selank para todo o mundo a partir da nossa rede dedicada de envio de peptídeos. As encomendas exclusivas de peptídeos qualificam-se para o nosso serviço de envio de peptídeos independente. Todas as encomendas são enviadas em embalagens com controlo de temperatura, com rastreio completo e estão cobertas pela nossa Política de Garantia de Reenvio.
Other Peptides for Nootropic, Neuroprotective, and Cognitive Studies
- Semax — Sister heptapeptide from the same Russian clinical — nootropic and neuroprotective studies
- Epitalon — AEDG pineal tetrapeptide — longevity and circadian rhythm support
- BPC-157 — Body Protection Compound — healing and tissue-recovery
- KPV — Small immunomodulatory tripeptide — inflammation and barrier studies
- Adamax — Heptapeptide nootropic compound
Leitura Adicional
📖 Explore small-peptide nootropic studies
Explore a gama completa catálogo de péptidos, com compostos relacionados incluindo Semax for melanocortin-axis nootropic studies, Epitalon for pineal-peptide longevity studies, and Adamax for sister heptapeptide cognitive studies.















Avaliações
Ainda não existem avaliações